The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia
The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia
复制标题
DOI:
10.4049/jimmunol.165.1.397
复制
发表时间:
2000-07-01
影响因子:
4.4
通讯作者:
Conlon, PJ
中科院分区:
文献类型:
--
作者:
Boehme, SA;Lio, FM;Conlon, PJ
Fractalkine is a CX3C-family chemokine, highly and constitutively expressed on the neuronal cell surface, for which a clear CNS physiological function has yet to be determined. Its cognate receptor, CX3CR-1, is constitutively expressed on microglia, the brain-resident macrophages; however, these cells do not express fractalkine, We now show that treatment of microglia with fractalkine maintains cell survival and inhibits Fas ligand-induced cell death in vitro. Biochemical characterization indicates that this occurs via mechanisms that may include 1) activation of the phosphatidylinositol-3 kinase/protein kinase B pathway, resulting in phosphorylation and blockade of the proapoptotic functions of BAD; 2) up-regulation of the antiapoptotic protein Bcl-x(L); and 3) inhibition of the cleavage of BH3-interacting domain death agonist (BID), The observation that fractalkine serves as a survival factor for primary microglia in part by modulating the protein levels and the phosphorylation status of Bcl-2 family proteins reveals a novel physiological role for chemokines, These results, therefore, suggest that the interaction between fractalkine and CX3CR-1 may play an important role in promoting and preserving microglial cell survival in the CNS.